24 related articles for article (PubMed ID: 10658572)
1. 3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
Verma A; Wong DM; Islam R; Tong F; Ghavami M; Mutunga JM; Slebodnick C; Li J; Viayna E; Lam PC; Totrov MM; Bloomquist JR; Carlier PR
Bioorg Med Chem; 2015 Mar; 23(6):1321-40. PubMed ID: 25684426
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and In Silico Kinetic Studies of Patented 1,7-diEthyl and 1,7-diMethyl Aminoalkanol Derivatives as New Inhibitors of Acetylcholinesterase.
Grodner B; Napiórkowska M; Pisklak DM
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008697
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa.
Jung M; Park M
Molecules; 2007 Sep; 12(9):2130-9. PubMed ID: 17962731
[TBL] [Abstract][Full Text] [Related]
4. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
[TBL] [Abstract][Full Text] [Related]
5. Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates.
Krátký M; Štěpánková Š; Vorčáková K; Švarcová M; Vinšová J
Molecules; 2016 Feb; 21(2):. PubMed ID: 26875979
[TBL] [Abstract][Full Text] [Related]
6. Probing structure-function relationships of serine hydrolases and proteases with carbamate and thiocarbamate inhibitors.
Lin G; Chiou SY; Hwu BC; Hsieh CW
Protein J; 2006 Jan; 25(1):33-43. PubMed ID: 16721659
[TBL] [Abstract][Full Text] [Related]
7. Rate-limiting step in the decarbamoylation of acetylcholinesterases with large carbamoyl groups.
Rosenberry TL; Cheung J
Chem Biol Interact; 2019 Aug; 308():392-395. PubMed ID: 31175846
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics of acetylcholinesterase.
Shen T; Tai K; Henchman RH; McCammon JA
Acc Chem Res; 2002 Jun; 35(6):332-40. PubMed ID: 12069617
[TBL] [Abstract][Full Text] [Related]
9. Ortho effects in quantitative structure-activity relationships for acetylcholinesterase inhibition by aryl carbamates.
Lin G; Liu YC; Lin YF; Wu YG
J Enzyme Inhib Med Chem; 2004 Oct; 19(5):395-401. PubMed ID: 15648653
[TBL] [Abstract][Full Text] [Related]
10. Enantiomeric inhibitors of cholesterol esterase and acetylcholinesterase.
Lin G; Tsai YC; Liu HC; Liao WC; Chang CH
Biochim Biophys Acta; 1998 Oct; 1388(1):161-74. PubMed ID: 9774723
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition in acetylcholinesterase catalysis: free-energy correlations for substrate turnover and inhibition by trifluoro ketone transition-state analogs.
Nair HK; Seravalli J; Arbuckle T; Quinn DM
Biochemistry; 1994 Jul; 33(28):8566-76. PubMed ID: 8031791
[TBL] [Abstract][Full Text] [Related]
12. Quantitative structure-activity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates.
Lin G; Liao WC; Chan CH; Wu YH; Tsai HJ; Hsieh CW
J Biochem Mol Toxicol; 2004; 18(6):353-60. PubMed ID: 15674842
[TBL] [Abstract][Full Text] [Related]
13. Cage amines as the stopper inhibitors of cholinesterases.
Lin G; Tsai HJ; Tsai YH
Bioorg Med Chem Lett; 2003 Sep; 13(17):2887-90. PubMed ID: 14611850
[TBL] [Abstract][Full Text] [Related]
14. Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure-activity relationships for inhibitions by aryl carbamates.
Lin G; Lai CY; Liao WC
Bioorg Med Chem; 1999 Dec; 7(12):2683-9. PubMed ID: 10658572
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
